WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rani Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mir A. ImranDirector2025-10-232,083,334$0.61
$1.26MBuy
South Cone Investments Limited Partnership10% Owner2025-10-214,000,000$2.77
$11.07MSell
South Cone Investments Limited Partnership10% Owner2025-10-201,923,000$2.41
$4.64MSell

1 of 1

RANI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RANI insiders and whales buy or sell their stock.

RANI Shareholders

What type of owners hold Rani Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mir A. Imran20.12%24,891,346$20.19MInsider
South Cone Investments Limited Partnership7.26%8,975,682$7.28MInsider
Ra Capital Management LP6.87%8,500,000$6.89MInstitution
Samsara Biocapital LLC6.87%8,500,000$6.89MInstitution
Awm Investment Company Inc5.25%6,500,000$5.27MInstitution
Symbiosis Capital Partners LLC5.09%6,300,000$5.11MInstitution
Moreno Isidoro Quiroga4.26%5,272,750$4.28MInsider
Vanguard Group Inc4.13%5,109,368$4.14MInstitution
Longaeva Partners LP1.71%2,113,435$1.71MInstitution
Siren LLC1.62%2,000,000$1.62MInstitution

1 of 3

RANI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RANI36.22%33.04%Net Selling
KPTI20.88%79.12%Net SellingNet Selling
TTRX1.58%59.73%Net Buying
MSLE0.00%0.00%
BMEA32.13%25.19%Net Buying
View Top Biotech Stocks

Rani Therapeutics Holdings Stock Ownership FAQ

Who owns Rani Therapeutics Holdings?

Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 36.22% institutional shareholders, 33.04% Rani Therapeutics Holdings insiders, and 30.74% retail investors. Mir A. Imran is the largest individual Rani Therapeutics Holdings shareholder, owning 24.89M shares representing 20.12% of the company. Mir A. Imran's Rani Therapeutics Holdings shares are currently valued at $20.19M.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.